Besifloxacin Hydrochloride - CAS# 405165-61-9 Size:Solid 10 mg 35 micromol/l and 1

35 micromol/l and 1

improving the utilization of oxygen and glucose by brain cells

InChi: InChI=1S/C5H9Cl2N3O2/c6-1-3-8-5(11)10(9-12)4-2-7/h1-4H2

Smiles: COC1=CC=C(C=C1OC)C(=O)N1CCN(CC1)C1=CC2CCC(=O)NC=2C=C1

3-thiazol-2-yl]-1-{2-[2-(2-fluoroethyl)-2H-1

Besifloxacin Hydrochloride - CAS# 405165-61-9 Size:Solid 10 mg 35 micromol/l and 1Besifloxacin is a fourth generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride. It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U. S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated (OTCBB: INSV) in 2000. InSite Vision developed an eye drop formulation (ISV 403) and conducted preliminary clinical trials before selling the product and all rights to Bausch &